BioNTech | Results Presentation Deck | 30 slides · page 25 of 30
BioNTech | Results Presentation Deck | 30 slides · slide 25
Conference presentation · kpi_overview · summarize · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
list 2/2 paragraph 3/3 table 1/1 title 1/1
Components 7
bullet bullet paragraph paragraph paragraph data headline
Tools 2
List presentation slide · 70%
list/bullet: Estimated COVID-19 vaccine revenues to BioNTech upon delivery of signed supply contracts as of May 4, 2021 (~1.8 billion doses): ~€12.4 billion
Table data slide · 70%table/data: R&D expenses: €750 million – €850 million; SG&A expenses: Up to €200 million; Capital expenditures: €175 million – €225 million
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.